|
urethra cancer
|
DOID_734 |
|
|
Osgood-Schlatter's disease
|
DOID_7489 |
|
|
anthracosis
|
DOID_10327 |
|
|
siderosis
|
DOID_10328 |
|
|
organ system benign neoplasm
|
DOID_0060085 |
|
|
EC 3.4.24.18 (meprin A) inhibitor
|
CHEBI_77745 |
|
|
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor
|
CHEBI_77748 |
|
|
EC 3.6.3.1 (phospholipid-translocating ATPase) inhibitor
|
CHEBI_77747 |
|
|
nuclear receptor modulator
|
CHEBI_90709 |
|
|
ATP/ADP translocase inhibitor
|
CHEBI_77750 |
|
|
Patau syndrome
|
DOID_11665 |
|
|
female stress incontinence
|
DOID_724 |
|
|
conduct disorder
|
DOID_12995 |
|
|
blue color blindness
|
DOID_11661 |
|
|
normocytic anemia
|
DOID_720 |
|
|
retinoic acid receptor alpha antagonist
|
CHEBI_90713 |
|
|
retinoic acid receptor antagonist
|
CHEBI_90714 |
|
|
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
|
CHEBI_77763 |
|
|
blepharophimosis
|
DOID_10348 |
|
|
onchocerciasis
|
DOID_11678 |
|
